RELATED CONTENT
NEWS
- Merck indicates launch/pricing plans for Victrelis in Europe
- Express Scripts $29.1 billion bid for Medco will hit US FTC scrutiny and squeeze pharma
- AMAG, Allos to merge – but will it really bring sales synergies for Feraheme, Folotyn?
- Upcoming Bydureon US resubmission fails to boost Amylin

